|
Volumn 144, Issue 6, 2008, Pages 820-822
|
Sorafenib-induced eruptive melanocytic lesions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SORAFENIB;
ADULT;
CASE REPORT;
CLINICAL FEATURE;
DRUG ERUPTION;
ERUPTIVE MELANOCYTIC LESION;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
KIDNEY CARCINOMA;
LENTIGO;
LETTER;
MALE;
MELANOCYTIC NEVUS;
PRIORITY JOURNAL;
SKIN EXAMINATION;
TREATMENT DURATION;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
BIOPSY;
CARCINOMA, RENAL CELL;
DIAGNOSIS, DIFFERENTIAL;
DRUG ERUPTIONS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEVUS, PIGMENTED;
PYRIDINES;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
SKIN;
SKIN NEOPLASMS;
|
EID: 45349100306
PISSN: 0003987X
EISSN: 0003987X
Source Type: Journal
DOI: 10.1001/archderm.144.6.820 Document Type: Letter |
Times cited : (72)
|
References (7)
|